| D-optimal design in the development of rheologically improved in situ forming ophthalmic gel I Krtalić, S Radošević, A Hafner, M Grassi, M Nenadić, B Cetina-Čižmek, ... Journal of pharmaceutical sciences 107 (6), 1562-1571, 2018 | 56 | 2018 |
| Lipid/alginate nanoparticle-loaded in situ gelling system tailored for dexamethasone nasal delivery BJ Dukovski, I Plantić, I Čunčić, I Krtalić, M Juretić, I Pepić, J Lovrić, ... International journal of pharmaceutics 533 (2), 480-487, 2017 | 37 | 2017 |
| HCE-T cell-based permeability model: A well-maintained or a highly variable barrier phenotype? M Juretić, BJ Dukovski, I Krtalić, S Reichl, B Cetina-Čižmek, ... European journal of pharmaceutical sciences 104, 23-30, 2017 | 31 | 2017 |
| Development of a robust SFC method for evaluation of compatibility for a novel antituberculotic fixed-dose combination V Petruševska, I Krtalić, A Rašić, A Mornar Analytical methods 11 (13), 1777-1787, 2019 | 8 | 2019 |
| Towards the development of a biorelevant in vitro method for the prediction of nanoemulsion stability on the ocular surface BJ Dukovski, J Ljubica, P Kocbek, MS Kučuk, I Krtalić, A Hafner, I Pepić, ... International journal of pharmaceutics 633, 122622, 2023 | 7 | 2023 |
| A long-acting subcutaneous injectable formulation of olanzapine is designed to eliminate the causes of post-injection delirium/sedation syndrome I Krtalić, M Juretić, A Komlosi, IŠ Jerbić, M Prpić, T Szabo, ... Neuroscience Applied 3, 104230, 2024 | | 2024 |
| Razvoj biofarmaceutski unaprijeđenih nanoemulzija za oftalmičku primjenu loteprednol etabonata J Ljubica, B Jurišić Dukovski, I Krtalić, M Juretić, A Hafner, I Pepić, J Lovrić 7. Hrvatski kongres farmacije sa međunarodnim sudjelovanjem: knjiga sažetaka …, 2024 | | 2024 |
| Ophthalmic nanoemulsion with loteprednol etabonate–preformulation parameters for a highly loaded formulation J Ljubica, B Jurišić Dukovski, I Krtalić, I Sušanj, I Pepić, J Lovrić Makedonski farmacevtski bilten= Macedonian pharmaceutical bulletin 69, 63-64, 2023 | | 2023 |
| Loteprednol etabonate-loaded nanoemulsions for the treatment of dry eye disease: quality by design approach J Ljubica, B Jurišić Dukovski, D Špoljarić, I Krtalić, I Sušanj, A Hafner, ... 14th Central European Symposium on Pharmaceutical Technology 69 (1), 65-66, 2023 | | 2023 |
| Cultural Diversity and the Politics of Emotion in Media I Krtalić, S Božić-Vrbančić IUAES Congress 2020: Coming of Age on Earth: Legacies and Next Generation …, 2021 | | 2021 |
| Usporedba UHPLC i kiralne SFC za razdvajanje izoniazida i njegovih onečišćenja V Petruševska, I Krtalić, A Mornar 6. hrvatski kongres farmacije s međunarodnim sudjelovanjem: Novo doba …, 2019 | | 2019 |
| Development of innovative in situ forming gels for topical ophthalmic delivery I Krtalić University of Zagreb. Faculty of Pharmacy and Biochemistry. Department of …, 2018 | | 2018 |
| Rational approach for designing an optimal in situ gelling ophthalmic system I Krtalić, S Radošević, A Hafner, B Cetina-Čižmek, J Filipović-Grčić, ... 11th Central European Symposium o Pharmaceutical Technology, 2016 | | 2016 |
| Dizajn in situ gela za oftalmičku primjenu na bazi poloksamera P407 i P188 I Krtalić, B Cetina Čižmek, J Lovrić 5. Hrvatski kongres farmacije s međunarodnim sudjelovanjem, 183-183, 2015 | | 2015 |
| Prikladnost in vitro epitelnog modela rožnice u ispitivanjima bioraspoloživosti lijeka u oku M Juretić, L Karačić, M Togonal, A Blažević, I Čaklec, I Krtalić, J Lovrić 5. Hrvatski kongres farmacije s međunarodnim sudjelovanjem, 177-177, 2015 | | 2015 |
| Development of coupled in vitro/ex vivo models to predict eye-related bioavailability M Juretić, J Lovrić, I Krtalić, B Cetina-Čižmek, I Pepić, J Filipović-Grčić 10th Central European Symposium on Pharmaceutical Technology, 137-138, 2014 | | 2014 |
| TV-44749, A LONG-ACTING SUBCUTANEOUS (SC) INJECTABLE FORMULATION OF OLANZAPINE IS DESIGNED TO PROVIDE SUSTAINED CONTROLLED CONCENTRATIONS AND TO ELIMINATE THE CAUSES OF POST … I Krtalić, M Juretić, A Komlosi, IŠ Jerbić, M Prpić, T Szabo, ... 2024 Annual Congress of the Schizophrenia International Research Society, 0 | | |
| Development of ophthalmic nanoemulsion for advanced delivery of poorly water-and oil-soluble loteprednol etabonate J Ljubica, B Jurišić Dukovski, D Špoljarić, I Krtalić, I Sušanj, A Hafner, ... IAPC-10 Meeting: Joint World Conferences on Physico Chemical Methods in Drug …, 0 | | |
| Investigation of biorelevant dilution as a driving force for nanoemulsion drug release at the ocular surface J Ljubica, B Jurišić Dukovski, M Juretić, I Krtalić, A Hafner, J Lovrić CRS 2024 Annual Meeting & Exposition, 0 | | |
